Rosemary Foster

4.2k total citations · 1 hit paper
46 papers, 3.1k citations indexed

About

Rosemary Foster is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Rosemary Foster has authored 46 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 22 papers in Oncology and 7 papers in Immunology. Recurrent topics in Rosemary Foster's work include Cancer Cells and Metastasis (10 papers), Ovarian cancer diagnosis and treatment (6 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Rosemary Foster is often cited by papers focused on Cancer Cells and Metastasis (10 papers), Ovarian cancer diagnosis and treatment (6 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Rosemary Foster collaborates with scholars based in United States, Netherlands and Hungary. Rosemary Foster's co-authors include Bo R. Rueda, Michael V. Seiden, Whitfield B. Growdon, Paul P. Szotek, David T. MacLaughlin, Patricia K. Donahoe, David Dombkowski, Denise C. Connolly, Rafael Pieretti‐Vanmarcke and Daniela M. Dinulescu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Rosemary Foster

45 papers receiving 3.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

2006 612 citations Paul P. Szotek, Rafael Pieretti‐Vanmarcke et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rosemary Foster United States	29	1.7k	1.6k	649	469	440	46	3.1k
Enrica Martinelli Italy	23	1.5k 0.9×	1.0k 0.7×	502 0.8×	302 0.6×	219 0.5×	44	3.1k
Miguel Abal Spain	34	1.7k 1.0×	1.1k 0.7×	882 1.4×	216 0.5×	263 0.6×	83	3.1k
Sanaz Memarzadeh United States	23	1.1k 0.6×	918 0.6×	424 0.7×	345 0.7×	509 1.2×	60	2.3k
Hee Jung An South Korea	27	1.3k 0.7×	818 0.5×	766 1.2×	286 0.6×	181 0.4×	76	2.5k
Aya Kobayashi Japan	18	1.3k 0.8×	1.2k 0.8×	536 0.8×	391 0.8×	106 0.2×	46	2.5k
Regina S. Whitaker United States	34	2.2k 1.3×	1.7k 1.0×	877 1.4×	673 1.4×	1.5k 3.4×	72	4.3k
Peixin Dong Japan	35	2.4k 1.4×	942 0.6×	1.8k 2.8×	366 0.8×	198 0.5×	72	3.4k
Emiliano Cocco United States	32	1.1k 0.6×	1.6k 1.0×	532 0.8×	294 0.6×	351 0.8×	83	3.2k
Mauricio Cuello Chile	25	984 0.6×	823 0.5×	527 0.8×	275 0.6×	249 0.6×	72	2.4k
Kathy Q. Cai United States	34	2.2k 1.3×	1.0k 0.6×	940 1.4×	290 0.6×	313 0.7×	117	3.7k

Countries citing papers authored by Rosemary Foster

Since Specialization

Citations

This map shows the geographic impact of Rosemary Foster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary Foster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary Foster more than expected).

Fields of papers citing papers by Rosemary Foster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary Foster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary Foster. The network helps show where Rosemary Foster may publish in the future.

Co-authorship network of co-authors of Rosemary Foster

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemary Foster. A scholar is included among the top collaborators of Rosemary Foster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemary Foster. Rosemary Foster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bellio, Chiara, Rosemary Foster, Kaitlyn E. James, et al.. (2018). PARP Inhibition Induces Enrichment of DNA Repair–Proficient CD133 and CD117 Positive Ovarian Cancer Stem Cells. Molecular Cancer Research. 17(2). 431–445. 46 indexed citations

Cardozo, Eden R., Rosemary Foster, Anatte E. Karmon, et al.. (2018). MicroRNA 21a-5p overexpression impacts mediators of extracellular matrix formation in uterine leiomyoma. Reproductive Biology and Endocrinology. 16(1). 46–46. 33 indexed citations

Faustman, Denise L., Heather Torrey, John Butterworth, et al.. (2017). Targeting the TNFR2 oncogene on tumor cells and tregs of the tumor microenvironment via dominant TNFR2 antagonism.. Journal of Clinical Oncology. 35(7_suppl). 106–106.

Hernández, Sílvia, et al.. (2016). Ridaforolimus improves the anti-tumor activity of dual HER2 blockade in uterine serous carcinoma in vivo models with HER2 gene amplification and PIK3CA mutation. Gynecologic Oncology. 141(3). 570–579. 5 indexed citations

Diver, Elisabeth, Rosemary Foster, Bo R. Rueda, & Whitfield B. Growdon. (2015). The Therapeutic Challenge of Targeting HER2 in Endometrial Cancer. The Oncologist. 20(9). 1058–1068. 64 indexed citations

Growdon, Whitfield B., Jolijn W. Groeneweg, Darrell R. Borger, et al.. (2015). HER2 over-expressing high grade endometrial cancer expresses high levels of p95HER2 variant. Gynecologic Oncology. 137(1). 160–166. 30 indexed citations

Gao, Yan, Rosemary Foster, Xiaoqian Yang, et al.. (2015). Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer. Oncotarget. 6(11). 9313–9326. 113 indexed citations

Gao, Yan, Rosemary Foster, Francis J. Hornicek, Mansoor M. Amiji, & Zhenfeng Duan. (2015). Abstract 352: Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer. Cancer Research. 75(15_Supplement). 352–352. 1 indexed citations

Groeneweg, Jolijn W., T.R. Hall, Ling Zhang, et al.. (2014). Inhibition of gamma-secretase activity impedes uterine serous carcinoma growth in a human xenograft model. Gynecologic Oncology. 133(3). 607–615. 15 indexed citations

10.

Groeneweg, Jolijn W., Sílvia Hernández, Minji Kim, et al.. (2014). Dual HER2 Targeting Impedes Growth of HER2 Gene–Amplified Uterine Serous Carcinoma Xenografts. Clinical Cancer Research. 20(24). 6517–6528. 19 indexed citations

11.

Bradford, Leslie, Rachel M. Clark, Jolijn W. Groeneweg, et al.. (2014). Assessing the efficacy of targeting the phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway in endometrial cancer. Gynecologic Oncology. 133(2). 346–352. 29 indexed citations

12.

Bradford, Leslie, Jose Alejandro Rauh‐Hain, Rachel M. Clark, et al.. (2013). Targeting the PI3K signaling cascade in PIK3CA mutated endometrial cancer in a primary human xenograft model.. Journal of Clinical Oncology. 31(15_suppl). e13564–e13564. 1 indexed citations

13.

Friel, Anne M., Lingling Zhang, Michael D. Curley, et al.. (2010). Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells. Reproductive Biology and Endocrinology. 8(1). 147–147. 47 indexed citations

14.

Jiang, Wei, Martha Betson, Roseann Mulloy, et al.. (2008). p190A RhoGAP Is a Glycogen Synthase Kinase-3-β Substrate Required for Polarized Cell Migration. Journal of Biological Chemistry. 283(30). 20978–20988. 39 indexed citations

15.

Friel, Anne M., Petra Sergent, Paul P. Szotek, et al.. (2008). Functional analyses of the cancer stem cell-like properties of human endometrial tumor initiating cells. Cell Cycle. 7(2). 242–249. 70 indexed citations

16.

Duan, Zhenfeng, James E. Bradner, Edward F. Greenberg, et al.. (2007). 8-Benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic Acid (SD-1008), a Novel Janus Kinase 2 Inhibitor, Increases Chemotherapy Sensitivity in Human Ovarian Cancer Cells. Molecular Pharmacology. 72(5). 1137–1145. 35 indexed citations

17.

Szotek, Paul P., Rafael Pieretti‐Vanmarcke, Peter T. Masiakos, et al.. (2006). Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proceedings of the National Academy of Sciences. 103(30). 11154–11159. 612 indexed citations breakdown →

18.

Foster, Rosemary, et al.. (2006). Reclassification of a tubal leiomyosarcoma as an eGIST by molecular evaluation of c-KIT. Gynecologic Oncology. 101(2). 363–366. 27 indexed citations

19.

Duan, Zhenfeng, Rosemary Foster, Katherine A. Brakora, Rushdia Z. Yusuf, & Michael V. Seiden. (2005). GBP1 overexpression is associated with a paclitaxel resistance phenotype. Cancer Chemotherapy and Pharmacology. 57(1). 25–33. 50 indexed citations

20.

Settleman, Jeffrey & Rosemary Foster. (1995). [13] Purification and GTPase-activating protein activity of baculovirus expressed p190. Methods in enzymology on CD-ROM/Methods in enzymology. 256. 105–113. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact